BioMark

BioMark Diagnostics Inc. develops early-stage cancer diagnostic technologies. The company creates non-invasive liquid biopsy platforms to detect and monitor various cancers. Its approach yields sensitive diagnostic tools, crucial for improving patient outcomes through early disease identification and timely medical interventions.

Founded by Rashid Ahmed Maula Bux, also President and CEO, BioMark Diagnostics Inc. originated from Bux's vision to leverage scientific advancements, specifically nanotechnology, for medical applications. His insight focused on exploring novel diagnostic pathways for unmet needs in cancer detection, establishing the company’s dedication to early and accurate identification.

BioMark Diagnostics Inc. develops products for the medical community, benefiting patients through proactive disease management. The company’s vision is to enhance global health outcomes by facilitating earlier cancer detection. By providing reliable tools, BioMark aims to transform cancer diagnosis and treatment, improving quality of life and survival rates worldwide.